Sanofi India net moves up by 37.5% in Q1, Charles Billard will be new CFO
New Delhi: Drug firm Sanofi India on Tuesday reported 37.27 per cent rise in net profit to Rs 82.5 crore for the quarter ended March 31, 2018.
The company had posted a net profit of Rs 60.1 crore in January-March period of 2016-17, Sanofi India said in a filing to BSE.
Total revenue from operations also rose to Rs 617.7 crore as against Rs 552.9 crore earlier, it added.
In a separate filing , the company said its board has approved appointment of Charles Billard as Chief Financial Officer and key Managerial Personnel with effect from July 1, 2018.
Shares of Sanofi India were today trading at Rs 4,890.85 per scrip on BSE, up 1.17 percent from its previous close.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd